Enovis ENOV
NYSE ENOV
$26.77 +0.27 (+1.02%)
At close: Aug 20, 2026 · 11:15 AM UTC

Enovis (ENOV) Non Operating Investment Income (2018 - 2022)

Enovis (ENOV) posted quarterly Non Operating Investment Income of $30.3 million for Q4 2022, up 244.32% quarter-over-quarter from $8.8 million in Q3 2022.

Enovis (ENOV) Non Operating Investment Income (2018 - 2022) Analysis & Trends

Enovis (ENOV) has reported Non Operating Investment Income for 2 consecutive years, with $30.3 million the latest figure, recorded in Q4 2022.

  • In Q4 2022, Non Operating Investment Income changed N/A year-over-year to $30.3 million; the TTM figure through Dec 2023 stood at $39.1 million (down 77.61% YoY), while the FY2022 annual figure was $102.7 million, changed N/A from the prior year.
  • Non Operating Investment Income rose to $30.3 million in Q4 2022 per ENOV's latest filing, from $8.8 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $135.5 million in Q3 2022 and bottomed at -$14.7 million in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn -
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn -
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn -
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn -
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn -
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn -
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn -
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn -
10 Enovis 1.54 Bn 1.52 Bn 359.25 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 30.30 Mn
Dec 31, 2022 30.30 Mn
Sep 30, 2022 8.80 Mn
Sep 30, 2022 8.80 Mn
Jul 1, 2022 135.50 Mn
Jul 1, 2022 135.50 Mn
Dec 31, 2018 -28,000.00
Dec 31, 2018 -28,000.00
Jun 29, 2018 4.59 Mn
Jun 29, 2018 4.59 Mn
Mar 30, 2018 -14.72 Mn
Mar 30, 2018 -14.72 Mn